SEC Form 4 insider trading filings tracked in real time from EDGAR

Ogden Christopher — Chief Financial Officer

Insider trading activity for Ogden Christopher sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: CytomX Therapeutics, Inc.
  • Total insider trades: 1
  • Total buy volume: $0
  • Total sell volume: $124K
  • Last trade: Mar 19, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Mar 17, 2026 Ogden Christopher CTMX CytomX Therapeutics, Inc. SELL 19,323 $124K

← All executives · Full trades feed